Clinical Trials Browser

Phase 2 × Has results × Neoplastic Cells, Circulating × Clear all

NCT03070002 2018-11-20

Denosumab in Treating Patients With ER and/or PR Positive, HER2 Negative Metastatic Breast Cancer With Bone Metastases and Detectable Circulating Tumor Cells

Phase 2 Terminated

1 enrolled 6 charts

Breast Neoplasms, Neoplastic Cells, Circulating

NCT00429182 2013-04-10

Purged Circulating Tumor Cells (CTCs) From Metastatic Breast Cancer

Phase 2 Completed

32 enrolled 6 charts

Breast Neoplasms, Neoplastic Cells, Circulating